This inventor holds 2 USPTO granted patents. Top assignee: Sandoz Ag. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2017
Title: The Innovations of Hansjorg Toll
Introduction
Hansjorg Toll is a notable inventor based in Kundl, Austria. He has made significant contributions to the field of therapeutic applications through his innovative work. With a total of 2 patents, Toll has focused on advancing methods related to fusion proteins.
Latest Patents
One of Hansjorg Toll's latest patents is centered on the "Quantification of misfolded TNFR2:Fc." This invention is directed towards methods for determining the relative amount of wrongly disulphide bridged TNFR2:Fc in a sample. TNFR2:Fc is a fusion protein utilized in various therapeutic applications. Additionally, the invention includes a method for purifying TNFR2:Fc using the aforementioned quantification method, leading to improved TNFR2:Fc compositions.
Career Highlights
Hansjorg Toll is currently associated with Sandoz AG, a prominent company in the pharmaceutical industry. His work at Sandoz AG has allowed him to explore and develop innovative solutions in the realm of therapeutic proteins.
Collaborations
Throughout his career, Toll has collaborated with esteemed colleagues such as Alfred Rupprechter and Michael Fuchs. These collaborations have further enriched his research and development efforts.
Conclusion
Hansjorg Toll's contributions to the field of therapeutic applications through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the use of fusion proteins in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile